Prescribing Patterns of Antidiabetic in Patients with Type 2 Diabetes Mellitus at Levy and Chilenje Hospitals in Zambia

Eddie M. Mulenga 1 * , Lawrence Mvula 2
More Detail
1 School of Doctoral Studies, The University of Valladolid, SPAIN
2 Faculty of Pharmacy, Nutrition & Dietetics, Lusaka Apex Medical University, ZAMBIA
* Corresponding Author
EUR J BASIC MED SCI, Volume 11, Issue 3, pp. 30-37.
Download Full Text (PDF)


Objective: To determine the prescription pattern of anti-diabetics drugs in patients with type 2 diabetes at Levy Mwanawasa General and Chilenje Level 1 Hospitals.
Methods: A cross-sectional study was conducted by reviewing the diabetic patients’ prescriptions with diabetic drugs from outpatient department from January to December, 2016. Data generated from this study was analyzed using SPSS version 23. The P value < 0.05 was considered as significant. Descriptive statistics and one way analysis of variance (One way -ANOVA) statistical techniques were used to analyze data.
Results: Of the total of 384 patients’ prescriptions, 63% were female and the majority of patients belonged to the age group 51-60 years indicating 28%. 51% of the prescriptions had 2 to 3 antidiabetic drugs written by generic name. Metformin/Daonil combination was highly prescribed with 57%, followed by Metformin as Monotherapy at 19%.
Conclusion: This study reported that female patients were significantly more affected with diabetes associated with cardiovascular complications than male patients reviewing 37% for male and 67% female. Most of the patients were on combination therapy of Metformin /Glibenclamide in the frequency TDS/OD. The choice of drug based on demographic data, economic status, associated conditions and complications would give additional insights into prescribing patterns in type 2 diabetes mellitus.


Mulenga EM, Mvula L. Prescribing Patterns of Antidiabetic in Patients with Type 2 Diabetes Mellitus at Levy and Chilenje Hospitals in Zambia. EUR J BASIC MED SCI. 2021;11(3):30-7.


  • Haile F, Bule M, Gelaw B, Tegegne G, Defersha A. Anti-diabetic medication pattern in Adama Hospital Medical College East Shoa Zone, Oromia, Ethiopia. International Journal of Pharma Science, 2015; 5(4): 1200-8.
  • Sridevi S, Ganesh MA, Study on the prescription pattern of oral hypoglycemic agents in Type 2 Diabetes mellitus in the outpatient department of a tertiary care hospital Indian Journal of Applied Research, 2016; 6(3):116-7.
  • Diabetes Association of Zambia. 2015. Available at:
  • Prachi D, Chirag D, Aarti P, Desai S. A drug prescribing pattern study in Diabetes Mellitus: An outpatient study. Journal of Pharmaceutical Science and Bio Scientific Research, 2015; 5(1): 115-8.
  • Shahir A, Kauser S, Dharmender G, Ahmad A. Prescription patter of antidiabetic medications in a tertiary care teaching Hospital, Bareilly, India. Journal of Pharmaceutical and Scientific Innovation, 2013; 2(1): 41-6.
  • Simó R, Hernández C. Advances in the medical treatment of diabetic retinopathy. The National Center for Biotechnology Information, 2005; 32(8): 1556–62. doi: 10.2337/dc09-0565 PMid: 19638526 PMCid: PMC2713619.
  • Karim R, Saha R, Rahman S, et al. A survey of prescription pattern of anti-diabetic drugs on with cardiovascular complications within, Dhakametropolis. International Journal of Basic and Clinical Pharmacology, 2016; 5(1): 2397-402. doi: 10.18203/2319-2003.ijbcp20164095.
  • Ramachandran G, Rohith V, Topno I. Evaluation of prescribing pattern of anti-diabetic drugs using WHO prescribing indicators in a tertiary care Hospital. The Pharma Innovation Journal, 2015; 4(5): 76-80.
  • Ashar M, Hanif A, Jadoon A, et al. Assessment of Drug Use Pattern Using WHO Prescribing Indicators in the Medication Therapy of Indoor Diabetic Patients. International Journal of Basic Medical Sciences and Pharmacy, 2016; 6(1): 2049-4963.
  • Dutta S, Anjoom M, Beg M, Varma A, Bawa S. Study of prescribing pattern in diabetes mellitus patients in a tertiary care teaching hospital at Dehradun, Uttarakhand. International Journal of Medical Science and Public Health, 2014; 3(11): 1351-4. doi: 10.5455/ijmsph.2014.130820141.
  • Wold Health Organisation (WHO) 2016. Available at:
  • Verma S, Joshi Y, Singh A. Drug Utilization Evaluation of Anti-Diabetic Medication through Prescription Monitoring. Asian Journal of Pharmaceutical Research and Development. 2019; 7(3): 75-7. doi: 10.22270/ajprd.v7i3.537.
  • NCD Risk Factor Collaboration (NCD-RisC) – Africa Working Group. Trends in obesity and diabetes across Africa from 1980 to 2014: an analysis of pooled population-based studies. Int J Epidemiol. 2017; 46(5): 1421-32. doi: 10.1093/ije/dyx078 PMID: 28582528 PMCID: PMC5837192.
  • Nazarian-Samani Z, Sewell RDE, Lorigooini Z, Rafieian-Kopaei M. Medicinal Plants with Multiple Effects on Diabetes Mellitus and Its Complications: a Systematic Review. Curr Diab Rep. 2018; 18(10): 72. doi: 10.1007/s11892-018-1042-0 PMID: 30105479.
  • Lopez JM, Annunziata K, Bailey RA, Rupnow MF, Morisky DE. Impact of hypoglycemia on patients with type 2 diabetes mellitus and their quality of life, work productivity, and medication adherence. Patient Prefer Adherence. 2014 May 8;8:683-92. doi: 10.2147/PPA.S58813 PMID: 24855344 PMCID: PMC4020884.